Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : TAS-118
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : YAKULT HONSHA CO LTD
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 23, 2014
Lead Product(s) : TAS-118
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : YAKULT HONSHA CO LTD
Deal Size : Inapplicable
Deal Type : Inapplicable